glp 1 by lilly Novo, weight-loss drugs should be first option obesity treatments, European doctors say US approves new oral weight-loss

Lemme claims that the product acts to "promote GLP-1 production," reduce hunger and cravings," "promote fat reduction and healthy weight management" on the basis of "three clinically-studied ingredients." If Lemme argues in a motion to dismiss or its Answer that the case should be barred because a private consumer cannot bring a lawsuit based on lack of adequate substantiation, the plaintiffs may argue that "clinically studied" implies "clinically proven" or "clinically shown" and, therefore, may convey that the product has the level of support touted in the advertising

Food and Drug Administration-approved GLP-1 drugs for patients to use once a week

In 2021, the injectable form of semaglutide (Wegovy) was approved for treating obesity

M.LucotJ

The Sleep and Recovery Practices of Athletes Harvard Health

They should be used as a supplement to a healthy diet and exercise regime for sustainable weight management over the long term